Literature DB >> 32900820

Role of the hospital pharmacist in an Italian antimicrobial stewardship programme.

Piera Polidori1, Daniele Leonardi Vinci2, Silvia Adami3, Stefano Bianchi4, Maria Ernestina Faggiano5, Alessio Provenzani6.   

Abstract

The inappropriate use of antimicrobial agents is contributing to an increasing phenomenon of bacterial resistance. For this reason, there is a growing interest in 'antimicrobial stewardship', a series of coordinated and multidisciplinary interventions aimed to promote the safe and appropriate use of antimicrobials in which the pharmacist's contribution is necessary for the optimal choice of drug, dose, duration of therapy and the implementation of cost containment strategies. AIM OF THE STUDY: We wanted to create a reference model and a specific training manual on antibiotic stewardship to introduce the role of the department pharmacist with specific infection disease skills in the Italian health system hospitals.
METHODS: This study was conducted in six Italian hospitals for 24 months. It was divided into three phases: definition of indicators (as defined daily doses/100 days of hospitalisation, switches from intravenous (IV) to oral and from empirical to targeted therapies, etc) elaboration of research protocol; sharing, application and detection of the indicators and selection of centres involved; analysis and sharing of results and subsequent drafting and distribution of the training manual.Statistical analysis focused on possible differences between the frequencies of the aforementioned switches. Differences were analysed comparing the values recorded in the first quarter with those of the third quarter trough a χ² test. Statistical significance was set at p<0.05.
RESULTS: The pharmacist's work showed a statistically significant increase in the conversion from IV to oral antibiotic therapy (χ² (1.496)=9112 ; p=0.0025; df=1). It was also detected a 5% improvement in appropriate dosing, 34% reduction in drug stocks, 4% increase in allergy reports and 275% increase in the number of adverse drug reactions reported.
CONCLUSIONS: In this study, the interventions of the antibiotic stewardship pharmacist led to an improvement in quality of care, resource efficiency and healthcare professional awareness. © European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adverse effects; clinical pharmacy; hospital pharmacy education; infection control; infectious diseases; internal medicine; quality in health care

Mesh:

Substances:

Year:  2020        PMID: 32900820      PMCID: PMC8899682          DOI: 10.1136/ejhpharm-2020-002242

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  12 in total

1.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

2.  Intervention to Reduce Broad-Spectrum Antibiotics and Treatment Durations Prescribed at the Time of Hospital Discharge: A Novel Stewardship Approach.

Authors:  Norihiro Yogo; Katherine Shihadeh; Heather Young; Susan L Calcaterra; Bryan C Knepper; William J Burman; Philip S Mehler; Timothy C Jenkins
Journal:  Infect Control Hosp Epidemiol       Date:  2017-03-06       Impact factor: 3.254

Review 3.  Antimicrobial stewardship.

Authors:  Pranita D Tamma; Sara E Cosgrove
Journal:  Infect Dis Clin North Am       Date:  2011-03       Impact factor: 5.982

4.  Pharmacists' role in antimicrobial stewardship and relationship with antibiotic consumption in hospitals: An observational multicentre study.

Authors:  Clément Ourghanlian; Nathanaël Lapidus; Marie Antignac; Christine Fernandez; Catherine Dumartin; Patrick Hindlet
Journal:  J Glob Antimicrob Resist       Date:  2019-07-16       Impact factor: 4.035

Review 5.  Antibiotic use: how to improve it?

Authors:  Marlies E J L Hulscher; Jos W M van der Meer; Richard P T M Grol
Journal:  Int J Med Microbiol       Date:  2010-08       Impact factor: 3.473

6.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-04-13       Impact factor: 9.079

7.  Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams.

Authors:  Kalvin Yu; Jay Rho; Marlene Morcos; Jim Nomura; Donald Kaplan; Keith Sakamoto; Doan Bui; Sandy Yoo; Jason Jones
Journal:  Am J Health Syst Pharm       Date:  2014-06-15       Impact factor: 2.637

8.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

9.  Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Amy L Pakyz; Michael Oinonen; Ronald E Polk
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

10.  A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals.

Authors:  Pedro Mas-Morey; Marta Valle
Journal:  Eur J Hosp Pharm       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.